Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.
National Heart & Lung Institute, Imperial College School of Medicine, London, UK.
K F
KF
Chung
P
P
Godard
E
E
Adelroth
J
J
Ayres
N
N
Barnes
P
P
Barnes
E
E
Bel
P
P
Burney
P
P
Chanez
G
G
Connett
C
C
Corrigan
J
J
de Blic
L
L
Fabbri
S T
ST
Holgate
P
P
Ind
G
G
Joos
H
H
Kerstjens
P
P
Leuenberger
C G
CG
Lofdahl
S
S
McKenzie
H
H
Magnussen
D
D
Postma
M
M
Saetta
S
S
Salmeron
P
P
Sterk
D000328:Adult; D000485:Allergens; D018927:Anti-Asthmatic Agents; D001249:Asthma / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D001993:Bronchodilator Agents; D002648:Child; D004781:Environmental Exposure; D006801:Humans
D000485:Allergens; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents